Send us Feedback

Infinity Pharmaceuticals (INFI)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Top Insider Trades: NAV, TXI, INFI, AGCO
TheStreet.com  Apr 17  Comment 
span.style4 {font-size: 10px; font-weight: bold; } span.style5 {font-size: 10px} By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading. NEW YORK (TheStreet) -- It is a victory for...
Infinity Pharmaceuticals (INFI) Prices 10M Share Offering from Holders at $40/Sh
StreetInsider.com  Apr 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Infinity+Pharmaceuticals+%28INFI%29+Prices+10M+Share+Offering+from+Holders+at+%2440Sh/8247466.html for the full story.
Infinity Pharma Prices 10M Shares at $40/Share
Benzinga  Apr 11  Comment 
Infinity Pharmaceuticals (INFI) Stockholders to Offer 8.5M Shares in Secondary Offering
StreetInsider.com  Apr 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Infinity+Pharmaceuticals+%28INFI%29+Stockholders+to+Offer+8.5M+Shares+in+Secondary+Offering/8242739.html for the full story.
Infinity Announces 8.5M Share Proposed Secondary Offering of Common Stock
Benzinga  Apr 9  Comment 
UPDATE: Jefferies Raises PT on Infinity Pharmaceuticals on IPI-145 Sales Potential
Benzinga  Mar 6  Comment 
In a report published Wednesday, Jefferies reiterated its Hold rating on Infinity Pharmaceuticals (NASDAQ: INFI), and raised its price target from $21.00 to $41.00. Jefferies noted, “Wider 4Q12 loss of ~$47M (vs. our loss estimate of ~$29M);...
MKM Partners Upgrades Infinity Pharmaceutical (INFI) to Buy
StreetInsider.com  Feb 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/MKM+Partners+Upgrades+Infinity+Pharmaceutical+%28INFI%29+to+Buy/8053947.html for the full story.
UPDATE: JP Morgan Initiates Infinity Pharmaceuticals at Overweight on Positive Data
Benzinga  Jan 31  Comment 
JP Morgan initiated coverage on Infinity Pharmaceuticals (NASDAQ: INFI) with an Overweight rating and a $42.00 price target. JP Morgan commented, "We are initiating coverage of Infinity Pharmaceuticals with an Overweight rating based on...
Benzinga's Top Initiations
Benzinga  Jan 31  Comment 
Janney Capital initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. The target price for Salix is set to $55. Salix's shares closed at $47.21 yesterday. Analysts at Leerink initiated coverage on shares...
Infinity Pharma (INFI) Sees FY13 Loss of $115M - $125M; Issues Ops Update
StreetInsider.com  Jan 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Infinity+Pharma+%28INFI%29+Sees+FY13+Loss+of+%24115M+-+%24125M%3B+Issues+Ops+Update/7989415.html for the full story.
Infinity Pharma (INFI) Amends Millennium Agreement Over PI3K Program
StreetInsider.com  Dec 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Infinity+Pharma+%28INFI%29+Amends+Millennium+Agreement+Over+PI3K+Program/7968909.html for the full story.
Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium
Benzinga  Dec 24  Comment 
Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma
Benzinga  Dec 24  Comment 




more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Grant Zeng
www.zacks.com




References

Retrieved from "http://www.wikinvest.com/stock/Infinity_Pharmaceuticals_(INFI)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki